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J.J. Fung, and T.E. Starzl 
PHOSPHATIDIC acids (PAs) are a group of molecules that play an important role in intracellular signaling. l 
Of the four species of PA known. one (PAl-a) is rapidly 
activated during inflammatory responses through lysophos-
phatidic acid acyl transferase (LPAAT).2 Lisofylline (LSF) 
is a potent inhibitor of LP AA T and is known to block the 
formation of PAl-a, thus attenuating or abrogating a broad 
array of proinfiammatory activities.3 Given its crucial role in 
suppressing the inflammatory cascade, we have attempted 
to studv the efficacy of LSF in abating or averting hyper-
acute ~enograft rej~ction (HAR) in the guinea pig to rat 
model. The adjuvant affect of steroid therapy was also 
investigated. 
MATERIALS AND METHODS 
Animals and Surgrcal Procedures. Hartley guinea pigs and LEW 
rats were used as donors and recipients. respectively. of heterotopic 
cardiac transplants. 
Experimelllai Design. Xenograft recipients received pcriopera-
tively. a bolus injection of methylprednisolone (MPS) and/or a 5- to 
J()·minute infusion of Lisofylline (Cell Therapeutics. Seattle. WA) 
according to the d()sage detailed in Tablt: 1. In addition to graft 
survival. compleml.!nt activity in the serum of treatl.!d and untreated 
rats was also dctcrminl.!d by uSing sensitized SRBC as targets in 
hemolvtic assays. Tissue biopsies from cardiac xenografts were 
"htaln~g -;eflallv after transplantation i<>r wutln.: histopathological 
examination. The Jeposillon of rat Ig\1. IgCJ. ;lnJ c:\ molecules III 
Ihc hlllpSIc\ ot xenotransplam.:J hc:~rts "as J..:termincJ bv sing!.:-
,(lIm Immunofluorescent staining. 
RESULTS AND DISCUSSION 
. \, l.kpi(tco in Tabk I. untreateJ rat:, hvperacutclv reJecteo 
!,!uinca pi!! hcarts in 12.2 :':: -L, minutc'i (group I). Prcop-
c'l'atlvl' trcatmcnt llf thc rccipi..:nt with LSF alone (group II) 
led to modest prolongation of heart survival (31 :t 9 
minutes; group II), which was further enhanced by the 
addition of a bolus injection of 100 mg MPS (group VI) or 
by a second infusion of LSF after revascularization (group 
III). The most significanteifect on graft survival was 
observed, however, when both LSF and MPS were admin-
istered pretransplant and postrevascularization (132.2 :t 39 
minutes, group VII). It must be noted that MPS given 
alone, either prior to transplantation (group IV) or else 
additionally postrevascularization (group V), had a minimal 
effect on prolonging xenograft survival (groups IV and V). 
Histopathological examination of biopsies obtained from 
rejected hearts in untreated recipients displayed character-
istic features of HAR with widespread thrombosis, hemor-
rhage, perivascular edema, and myocardial necrosis. Addi-
tionally, immunofluorescent studies revealed marked 
deposition of rat IgM and C3 on the endothelium of the 
coronary vessels and the microvasculature. Deposition of 
rat IgG was undetectable. Biopsies of heart xenografts 
obtained from animals in group VII 30 minutes after 
revascularization (while still beating), when subjected to 
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Table 1. Survival of Guinea Pig Cardiac Xenografts in LEW Rat Recipients Treated Peri operatively With Lisotylline (LSF) 
and Methylprednisolone (MPS) 
l")fOUP 
III 
IV 
V 
VI 
VII 
738 
5 
5 
5 
5 
5 
5 
LSF 125 mg/kg 
LSF 125 mg/kg 
MPS 100 mg/kg 
MPS 100 mg/kg 
Treatment 
LSF 125 mg MPS 100 mg/kg 
LSF 125 mg - MPS 100 mg/kg 
Postrevasculanzatlon x . SO p 
122 '43 
31.0 9.0 .01 vs G1 
LSF 60 mg/kg 80.5 87.2 
11.6 4.5 
MPS 50 mg/kg 23.0 11.3 
54.6 • 3·13 
LSF 60 mg ~ MPS 50 mg/kg 132.2 39.6 01 vs G5 
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immunofluorescent analysis, revealed the deposition of rat 
IgM and C3; moreover, light microscopic analysis showed 
retention of nonnal architecture with minimal changes 
characteristic of HAR. Histopathological findings at a later 
time (after rejection), however, were similar to those in 
animals in group II. In conclusion, the preliminary data 
obtained from this study suggest that LSF, when used alone 
or in combination with steroids, prolonged the survival of 
xenografts transplanted across discordant barriers. 
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